# Psilocybin-Assisted Psychotherapy for Anxiety in People With Stage IV Melanoma

> **NCT00979693** · PHASE2 · WITHDRAWN · sponsor: **Multidisciplinary Association for Psychedelic Studies**

## Conditions studied

- Anxiety
- Stage IV Melanoma

## Interventions

- **DRUG:** psilocybin
- **DRUG:** psilocybin

## Key facts

- **NCT ID:** NCT00979693
- **Lead sponsor:** Multidisciplinary Association for Psychedelic Studies
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2012-01
- **Primary completion:** 2013-04
- **Final completion:** 2013-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The study was suspended because the PI was unable to get permission from his department to submit the protocol to the local IRB?"
- **Last updated:** 2023-12-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00979693

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00979693, "Psilocybin-Assisted Psychotherapy for Anxiety in People With Stage IV Melanoma". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00979693. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*